UBS Group AG - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 38 filers reported holding SIGILON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$658
-83.6%
708
-72.4%
0.00%
Q1 2022$4,000
-77.8%
2,568
-60.7%
0.00%
Q4 2021$18,000
+200.0%
6,531
+549.2%
0.00%
Q3 2021$6,000
-80.6%
1,006
-65.0%
0.00%
Q2 2021$31,000
-8.8%
2,877
+87.3%
0.00%
Q1 2021$34,000
+36.0%
1,536
+197.1%
0.00%
Q4 2020$25,0005170.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders